1
Evaluation of the Safety, Tolerability and Immunogenicity of VARIVAX™ in Healthy Russians (V210-058)
Condition(s):VaricellaLast Updated:April 10, 2020Active, not recruiting
VARIVAX: 141 Clinical Trials, Page 1 of 15
Hide Studies Not Open or Pending
2
Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)
Condition(s):VaricellaLast Updated:April 12, 2017Completed
3
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Condition(s):Persistence of Varicella ImmunityLast Updated:January 18, 2020Not yet recruiting
4
Re-examination Study For Varivax (V210-059 AM2)
Condition(s):VaricellaLast Updated:September 4, 2015Completed
5
Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)
Condition(s):VaricellaLast Updated:November 19, 2019Completed
6
Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)
Condition(s):VaricellaLast Updated:October 30, 2018Completed
7
A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)
Condition(s):Varicella; Herpes ZosterLast Updated:September 15, 2017Completed
8
A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)
Condition(s):VaricellaLast Updated:January 27, 2015Withdrawn
9
The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination
Condition(s):VaricellaLast Updated:May 29, 2013Unknown status
10
Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age
Condition(s):VaricellaLast Updated:May 8, 2019Completed